Conversely, PAX2 overexpression is associated with cystic or tumorous epithelial overgrowth [14], such as renal cystic dysplasia, renal cell carcinoma, Wilms’ tumor, nephrogenic adenoma, prostate cancer, breast cancer and ovarian cancer [15–19]. This evidence concerns the gene PAX2 and prostate carcinoma.